NanoVibronix Inc. - Bathi resik saben saham sajrone patang kuartal pungkasan NAOV

NanoVibronix, Inc. (NAOV) develops ultrasonic wound therapy systems targeting the wearable devices market. Analyzing the current state of annual EPS TTM growth on GURU.Markets, we note that the value 28.70 serves as the baseline indicator. However, logistical disruptions and sanctions are hindering expansion, while a lack of insurance reimbursement in the US combined with net losses is weighing on working capital.
NanoVibronix Inc. - rincian analitis lan metrik utama (NAOV)

The selection of high-quality issuers is based on earnings per share (EPS) dynamics. This metric measures the rate of change in net income over the last 12 months relative to the previous year, determining the speed of business recovery. For NanoVibronix, Inc. (NAOV), this growth is supported by the humanitarian status of its medical devices, which eliminates trade barriers. It is critical for investors to track the current EPS TTM annual growth rate to assess margin sustainability. The indicator's dynamics confirm the fundamental viability of the model.